These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29391198)

  • 21. The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients.
    Sanz-Bueno J; Lora D; Monsálvez V; Maroñas-Jiménez L; Postigo C; Rodríguez-Peralto JL; Ortiz-Romero PL
    Br J Dermatol; 2016 Oct; 175(4):794-6. PubMed ID: 26990536
    [No Abstract]   [Full Text] [Related]  

  • 22. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy.
    Rijlaarsdam U; Scheffer E; Meijer CJ; Kruyswijk MR; Willemze R
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):216-20. PubMed ID: 1826111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mycosis fungoides--the practionner confronted with the nosological, diagnostic and prognostic problems of epidermotrophic lymphomas (author's transl)].
    Puissant A; Durepaire RM; Tousch MA; Delanoe J; Saurat JH
    Dermatologica; 1978; 157(6):365-70. PubMed ID: 720716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment.
    Abel EA; Wood GS; Hoppe RT
    CA Cancer J Clin; 1993; 43(2):93-115. PubMed ID: 8439814
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenesis of Mycosis fungoides.
    Beyer M; Möbs M; Humme D; Sterry W
    J Dtsch Dermatol Ges; 2011 Aug; 9(8):594-8. PubMed ID: 21371258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH; Bishop K; Varghese A; Hoppe RT
    Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
    Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
    J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mycosis fungoides and its new paradigm].
    Quatresooz P; Piérard GE
    Rev Med Liege; 2010 Mar; 65(3):147-51. PubMed ID: 20411819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndrome.
    Evans KG; Troxel AB; DeNardo BJ; Introcaso CE; Rook AH; Kim EJ
    J Am Acad Dermatol; 2011 Apr; 64(4):682-9. PubMed ID: 21315479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycosis fungoides--a review of the management of 28 patients and of the recent literature.
    Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S
    Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulomatous mycosis fungoides.
    Telle H; Koeppel MC; Jreissati M; Andrac L; Horschowski N; Sayag J
    Eur J Dermatol; 1998; 8(7):506-10. PubMed ID: 9854165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States.
    Jones GW; Wilson LD
    Cancer; 1999 Jul; 86(1):191-3. PubMed ID: 10391580
    [No Abstract]   [Full Text] [Related]  

  • 33. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
    Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
    Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of malignant cutaneous lymphomas].
    Sterry W
    Dtsch Med Wochenschr; 1988 Feb; 113(5):184-9. PubMed ID: 3276493
    [No Abstract]   [Full Text] [Related]  

  • 35. A review of survival in mycosis fungoides.
    Vollmer RT
    Am J Clin Pathol; 2014 May; 141(5):706-11. PubMed ID: 24713743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
    Hughes CF; Newland K; McCormack C; Lade S; Prince HM
    Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.
    Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S
    Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The significance of epidermal changes in the early diagnosis and development of mycosis fungoides].
    Persina IS; Zabanova EV; Vavilov AM; Avervakh EV
    Arkh Patol; 1989; 51(2):40-6. PubMed ID: 2653281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and risk stratification in early mycosis fungoides.
    Vonderheid EC; Pavlov I; Delgado JC; Martins TB; Telang GH; Hess AD; Kadin ME
    Leuk Lymphoma; 2014 Jan; 55(1):44-50. PubMed ID: 23547839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purely follicular mycosis fungoides without mucinosis: report of two cases with review of the literature.
    Monopoli A; Annessi G; Lombardo GA; Baliva G; Girolomoni G
    J Am Acad Dermatol; 2003 Mar; 48(3):448-52. PubMed ID: 12637929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.